for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Thermo Fisher Scientific Inc.

TMO.N

Latest Trade

453.40USD

Change

4.95(+1.10%)

Volume

274,029

Today's Range

442.38

 - 

454.00

52 Week Range

250.29

 - 

532.52

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Thermo Fisher Scientific Elects New Director To Board

Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC ELECTS NEW DIRECTOR TO BOARD.THERMO FISHER SCIENTIFIC INC - R. ALEXANDRA "ALEX" KEITH APPOINTMENT BRINGS COMPANY'S TOTAL NUMBER OF BOARD MEMBERS TO 13..

Thermo Fisher Scientific Declares Quarterly Dividend And Authorizes $2.5 Billion Of Share Repurchases

Nov 5 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC DECLARES QUARTERLY DIVIDEND AND AUTHORIZES $2.5 BILLION OF SHARE REPURCHASES.

Thermo Fisher Scientific Extends Collaboration To Advance Biopharmaceutical Discovery And Development

Oct 29 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC EXTENDS COLLABORATION TO ADVANCE BIOPHARMACEUTICAL DISCOVERY AND DEVELOPMENT.THERMO FISHER SCIENTIFIC EXTENDS COLLABORATION TO ADVANCE BIOPHARMACEUTICAL DISCOVERY AND DEVELOPMENT.THERMO FISHER SCIENTIFIC - CO, SYMPHOGEN ANNOUNCE EXTENSION OF A STRATEGIC COLLABORATION.

Thermo Fisher Scientific Reports Third Quarter 2020 Adjusted Earnings Per Share $5.63

Oct 21 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC REPORTS THIRD QUARTER 2020 RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $5.63.Q3 GAAP EARNINGS PER SHARE $4.84.Q3 EARNINGS PER SHARE ESTIMATE $4.31 -- REFINITIV IBES DATA.Q3 REVENUE INCREASED 36% TO $8.52 BILLION.QTRLY ORGANIC REVENUE GROWTH WAS 34%.GENERATED $2.0 BILLION OF COVID-19 RELATED REVENUE IN QUARTER.Q3 REVENUE VIEW $7.65 BILLION -- REFINITIV IBES DATA.

Thermo Fisher Scientific Increases COVID-19 Testing Availability With Collection Kit From Everlywell

Oct 19 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC INCREASES AVAILABILITY OF COVID-19 TESTING WITH SAMPLE COLLECTION KIT FROM EVERLYWELL.THERMO FISHER SCIENTIFIC - RECEIVED EXPANSION OF EUA FOR TAQPATH COVID-19 COMBO KIT TO INCLUDE EVERLYWELL'S ADDITIONAL SAMPLE COLLECTION METHOD.

Thermo Fisher Scientific Says Plans To Develop Two New Sterile Filling Lines In Singapore

Oct 14 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC - PLANS TO DEVELOP TWO NEW STERILE FILLING LINES IN SINGAPORE.THERMO FISHER SCIENTIFIC - NEW FACILITIES IN SINGAPORE TO EXTEND CAPACITY TO ASIA-PACIFIC REGION FOR DEVELOPMENT, MANUFACTURE OF THERAPIES & VACCINES.THERMO FISHER SCIENTIFIC - NEW FACILITY TO BE ESTABLISHED WITH SUPPORT OF SINGAPORE ECONOMIC DEVELOPMENT BOARD.THERMO FISHER SCIENTIFIC - ONCE OPERATIONAL IN 2022, NEW FACILITY COULD MANUFACTURE UP TO 30 MILLION STERILE DOSES PER MONTH, EMPLOY MORE THAN 300 PEOPLE.

Thermo Fisher Scientific Expect Full Year 2020 Organic Revenue Growth To Be In The Range Of 13% To 16%

Sept 10 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::UPDATE WILL INCLUDE EXPECTED THIRD QUARTER ORGANIC REVENUE1 GROWTH OF 24%.ESTIMATES Q4 ORGANIC REVENUE GROWTH IS A RANGE OF 13% TO 27%.FULL YEAR 2020 ORGANIC REVENUE GROWTH IS EXPECTED TO BE IN THE RANGE OF 13% TO 16%.EXPECT FULL YEAR 2020 ORGANIC REVENUE GROWTH TO BE IN THE RANGE OF 13% TO 16%..Q3 REVENUE VIEW $7.24 BILLION -- REFINITIV IBES DATA.Q4 REVENUE VIEW $7.76 BILLION -- REFINITIV IBES DATA.FY2020 REVENUE VIEW $28.13 BILLION -- REFINITIV IBES DATA.

FDA Approves First NGS-Based Companion Diagnostic For Ret Fusion-Positive Non-Small Cell Lung Cancer

Sept 8 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::FDA APPROVES FIRST NGS-BASED COMPANION DIAGNOSTIC FOR RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER.THERMO FISHER SCIENTIFIC - COMPANION DIAGNOSTIC APPROVAL EXPANDS CLINICAL UTILITY OF ONCOMINE DX TARGET TEST TO IDENTIFY CANDIDATES FOR GAVRETO.THERMO FISHER SCIENTIFIC - TO UPDATE ONCOMINE DX TARGET TEST TO ENABLE IT TO REPORT RET FUSIONS IN U.S. BEFORE END OF YEAR.

Thermo Fisher Scientific Says Has Terminated Acquisition Agreement With Qiagen

Aug 13 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC ANNOUNCES RESULTS OF OFFER TO ACQUIRE QIAGEN, LAPSE OF OFFER AND TERMINATION OF ACQUISITION AGREEMENT.THERMO FISHER SCIENTIFIC INC - HAS TERMINATED ACQUISITION AGREEMENT WITH QIAGEN.THERMO FISHER SCIENTIFIC INC - QIAGEN WILL PAY TO THERMO FISHER AN EXPENSE REIMBURSEMENT PAYMENT OF USD 95 MILLION IN CASH.

Thermo Fisher Scientific Introduces New Automated, Real-Time PCR Solution

Aug 5 (Reuters) - Thermo Fisher Scientific Inc <TMO.N>::THERMO FISHER SCIENTIFIC - INTRODUCED A NEW AUTOMATED, REAL-TIME PCR SOLUTION DESIGNED TO ANALYZE UP TO 6,000 SAMPLES IN SINGLE DAY.THERMO FISHER SCIENTIFIC - WILL SUBMIT NEW END-TO-END SOLUTION TO U.S. FDA FOR EUA AND PLANS TO SECURE ADDITIONAL AUTHORIZATIONS GLOBALLY.THERMO FISHER SCIENTIFIC INC - AMPLITUDE SOLUTION UTILIZES CO'S APPLIED BIOSYSTEMS TAQPATH COVID-19 COMBO KIT.THERMO FISHER SCIENTIFIC - AMPLITUDE SOLUTION CUSTOMERS WILL ENTER INTO SUPPLY AGREEMENT WITH CO TO SECURE SUPPLY OF REAGENTS AND CONSUMABLES.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up